Nearly Two-Thirds of Two- And Three-Year-Olds Still to Receive Flu Vaccine, Government Data Show – The Pharmaceutical Journal

Government data indicate that just 37% of two- and three-year-olds in England have received their seasonal flu vaccine as of mid-November.

With influenza positivity rates climbing to 11.4%, health officials are urging parents to secure vaccinations to prevent severe complications, including pneumonia, as winter respiratory virus transmission levels begin to rise.

Clinical Insights for Parents

  • Direct Protection: The vaccine significantly reduces the risk of severe influenza, which is a leading cause of emergency department visits for children under five.
  • Community Immunity: Vaccinating young children slows viral spread, protecting vulnerable family members and younger siblings who cannot be immunized.
  • Accessible Care: Eligible children can receive the nasal spray vaccine through GP practices and participating community pharmacies, providing flexible options for busy families.

The UK Health Security Agency (UKHSA) reported that influenza positivity rose from 8.3% to 11.4% in the week ending 15 November 2026, The Pharmaceutical Journal reported. This uptick coincides with an increase in GP consultations for influenza-like illness, with the highest rates observed in children under one year (13.6 per 100,000) and those aged one to four years (13.1 per 100,000), according to data cited by ukpulse.co.uk.

Clinical concern remains high because children under five consistently represent the largest proportion of daily emergency department attendances for flu-related symptoms. As noted by the UKHSA, approximately 6,000 hospitalizations in children under five were recorded during the 2022–2023 winter season.

“It is a real concern that so many young children are left unprotected against flu every winter, with many thousands ending up in hospital, some in intensive care,” said Suzanna McDonald, flu vaccination programme lead at the UKHSA.

Nearly Two-Thirds of Two- And Three-Year-Olds Still to Receive Flu Vaccine, Government Data Show - The Pharmaceutical Journal
Photo: ukpulse.co.uk

The current vaccination strategy uses both primary care and community pharmacy networks. Since 1 October 2025, an advanced service pilot has allowed community pharmacies to administer vaccines to the two- and three-year-old cohort, a program extended in June 2026 by Community Pharmacy England.

“We would encourage parents to make sure their young children get their flu vaccine, particularly as we head into winter, and cases are starting to rise,” Mahendra Patel, chair of the Royal College of Pharmacy’s English Pharmacy Advisory Council, told The Pharmaceutical Journal.

Metric Current Data (Nov 2026)
Flu Positivity Rate 11.4%
Uptake (2-3 year olds) 37%
GP Consultations (1-4 yrs) 13.1 per 100,000

The immunological mechanism of the childhood flu vaccine—typically a live attenuated nasal spray—functions by inducing a localized mucosal immune response in the nasopharynx. By mimicking a natural viral exposure without causing the disease, it primes the adaptive immune system to recognize circulating influenza strains.

While efficacy varies by season and strain matching, a study published in June 2026 suggests that childhood flu vaccines can prevent between 9 and 14 cases of influenza per 100 children vaccinated, as reported by The Pharmaceutical Journal.

Government officials emphasize that the window for protection is closing as the peak season approaches. “Nothing should get in the way of children enjoying Christmas with family and friends,” said Dame Diana Johnson, Minister of State for Public Health and Patient Safety, in comments reported by birminghammail.co.uk.

“The free flu vaccine helps protect your 2 or 3 year old and the people they love, and can help keep them out of hospital this winter.”

Contraindications & When to Consult a Doctor

The nasal spray flu vaccine is generally contraindicated for children with a history of severe allergic reaction (anaphylaxis) to any component of the vaccine, or those with severe immunodeficiency. Parents should consult their GP if their child has a history of severe asthma or active wheezing, as these conditions may necessitate the use of an injectable inactivated vaccine instead.

Seek immediate medical intervention if a child exhibits signs of respiratory distress, such as rapid breathing, chest retractions, or persistent high fever, as these may indicate secondary complications like pneumonia.

The UK Health Security Agency (UKHSA), established in April 2021, consolidated Public Health England’s infectious disease control functions with NHS Test and Trace and the Joint Biosecurity Centre into a single executive agency of the Department of Health and Social Care responsible for health security in England.

It was initially proposed in July 2020 as the Centre for Health Protection and formally launched on 1 April 2021 under its current name, with Jenny Harries appointed chief executive after stepping down as England’s Deputy Chief Medical Officer.

For families who have not yet accessed the vaccine, appointments are available via the NHS App, local GP practices, or 119. For school-aged children who missed their initial window, additional opportunities will be available through school programs and select community pharmacies beginning 1 December 2026, according to ukpulse.co.uk.

Photo of author

Health Desk

Health Desk at Archyde.

Anthropic Shares Tumble, Surrendering Much of Debut Gain

Dark Horse Announces Marvel Black & White: New Mutants Hardcover for Aug. 24, 2027